Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study of 3D Printing Personalized Biodegradable Implant for Breast Reconstruction

NCT03348293 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT03348293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03348293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study of 3D Printing Personalized Biodegradable Implant for Breast Reconstruction
Lead sponsor
Xijing Hospital
Phase
Phase 1
Overall status
Completed
Start date
July 30, 2018
Completion date
December 30, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast reconstruction